215 related articles for article (PubMed ID: 7201494)
41. Systolic time interval characteristics in children with Duchenne's progressive muscular dystrophy.
Sanyal SK; Tierney RC; Rao PS; Pitner SE; George SL; Givins DR
Pediatrics; 1982 Dec; 70(6):958-64. PubMed ID: 7145553
[TBL] [Abstract][Full Text] [Related]
42. [Serum levels of beta-methyldigoxin and contractile efficiency of the myocardium evaluated with systolic polygraphy and determination of cardiac output].
Pelosi G; Bracchi G; Orazio S; Cereda A
Minerva Med; 1981 Feb; 72(4-5):225-31. PubMed ID: 7010220
[TBL] [Abstract][Full Text] [Related]
43. [Echocardiographic study for optimizing therapy with physiologic heart pacemakers--the relevance of mitral valve motion].
von Bibra H; Ebner U; Busch U; Klein G; Alt E; Wirtzfeld A
Z Kardiol; 1984 Jul; 73(7):460-5. PubMed ID: 6485472
[TBL] [Abstract][Full Text] [Related]
44. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
[No Abstract] [Full Text] [Related]
45. [Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil].
Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
Cas Lek Cesk; 1987 Mar; 126(11):330-4. PubMed ID: 3829106
[No Abstract] [Full Text] [Related]
46. Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy.
Petkow Dimitrow P; Krzanowski M; Nizankowski R; Szczeklik A; Dubiel JS
Heart; 2000 Mar; 83(3):262-6. PubMed ID: 10677401
[TBL] [Abstract][Full Text] [Related]
47. [Effect of single-dose verapamil on ventricular wall movement in hypertrophic cardiomyopathy].
Wang AA; Gu FS
Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Feb; 15(1):25-6. PubMed ID: 3608781
[No Abstract] [Full Text] [Related]
48. [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].
Kaltenbach M; Hopf R; Keller M
Dtsch Med Wochenschr; 1976 Aug; 101(35):1284-7. PubMed ID: 8298
[TBL] [Abstract][Full Text] [Related]
49. The evaluation of systolic time intervals and impedance cardiogram of neonates.
Kagiya A; Echizenya N; Hamada A; Tachizaki T; Satoh S; Saitoh Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):601-8. PubMed ID: 2754291
[TBL] [Abstract][Full Text] [Related]
50. Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.
Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF; Braunwald E
N Engl J Med; 1980 Oct; 303(14):801-3. PubMed ID: 7191052
[No Abstract] [Full Text] [Related]
51. Pharmacologic alterations of the isovolumic index: a study of the effects of isoproterenol, propranolol and verapamil.
McGillem MJ; DeBoe SF; Mancini GB
Can J Cardiol; 1989 Mar; 5(2):121-6. PubMed ID: 2706575
[TBL] [Abstract][Full Text] [Related]
52. [Phonomechanocardiography in dilated cardiomyopathy].
Meneghetti ML; Lépori OJ; Dumont CR
Arch Inst Cardiol Mex; 1985; 55(3):257-62. PubMed ID: 2932079
[TBL] [Abstract][Full Text] [Related]
53. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil.
Bonow RO; Frederick TM; Bacharach SL; Green MV; Goose PW; Maron BJ; Rosing DR
Am J Cardiol; 1983 May; 51(8):1386-91. PubMed ID: 6682616
[TBL] [Abstract][Full Text] [Related]
54. Isovolumic relaxation period in hypertrophic cardiomyopathy: assessment by radionuclide angiography.
Betocchi S; Bonow RO; Bacharach SL; Rosing DR; Maron BJ; Green MV
J Am Coll Cardiol; 1986 Jan; 7(1):74-81. PubMed ID: 3941220
[TBL] [Abstract][Full Text] [Related]
55. [Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil].
Bouhour JB; Potiron M; Chiffoleau S; Lefévre M; Louvet S
Arch Mal Coeur Vaiss; 1987 Jan; 80(1):76-82. PubMed ID: 3107495
[TBL] [Abstract][Full Text] [Related]
56. [The fetal systolic time intervals as an indicator of fetal hemodynamics--physiologic changes of the fetal systolic time intervals with fetal growth].
Suzuki A
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jul; 36(7):1048-56. PubMed ID: 6747388
[TBL] [Abstract][Full Text] [Related]
57. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
Lemke R; Hopf R; Kober G; Kaltenbach M
Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
[No Abstract] [Full Text] [Related]
58. Radionuclide ventriculography: acute and chronic response to verapamil in patients with hypertrophic cardiomyopathy.
Maul FD; Hopf R; Hör G; Standke R; Richter H; Olbrich HG; Happ J
Z Kardiol; 1987; 76 Suppl 3():39-45. PubMed ID: 3433873
[TBL] [Abstract][Full Text] [Related]
59. Isovolumic relaxation period in hypertrophic cardiomyopathy.
Alvares RF; Shaver JA; Gamble WH; Goodwin JF
J Am Coll Cardiol; 1984 Jan; 3(1):71-81. PubMed ID: 6537813
[TBL] [Abstract][Full Text] [Related]
60. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
Kober G; Hopf R; Biamino G; Bubenheimer P; Förster K; Kuck KH; Hanrath P; von Olshausen KE; Schlepper M; Kaltenbach M
Z Kardiol; 1987; 76 Suppl 3():113-8. PubMed ID: 3324526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
